Learn More
Medchemexpress LLC Nvp-tae 226 | 761437-28-9 | MFCD12031516 | 99.8% | C23H25ClN6O3 | 10MG

Supplier: Medchemexpress LLC HY1320310MG
NVP-TAE 226 is a potent, ATP-competitive small-molecule inhibitor of focal adhesion kinase (FAK) and insulin-like growth factor 1 receptor (IGF-1R), used in preclinical oncology and signal-transduction research. It exhibits activity across multiple kinases and has demonstrated antitumor effects in vitro and in vivo.
- Potent FAK inhibition (IC50 5.5 nM).
- Dual activity against IGF-1R and Pyk2 (IC50 140 nM and 3.5 nM).
- Additional activity against InsR, c-Met, KDR, and Flt3.
- High purity suitable for research (~99.8%).
- Stable as powder under recommended storage conditions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.